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An In Vivo Competitive Repopulation Assay System to Evaluate
Human Keratinocyte Stem Cells
To the Editor:
Reliable in vivo assays to assess the repopulation ability of
stem cell candidates are essential for progress in stem cell
research. We have designed an in vivo competitive re-
population assay that recapitulates human epidermis on
immunocompromised mice, and uses MHC-Class I markers
to distinguish and evaluate the relative abundance of long-
term repopulating keratinocytes and their progeny in the
epidermis. The accuracy and durability of this assay over
time is demonstrated.
The remarkable progress in hematopoietic stem cell re-
search has been driven by the development of sophisti-
cated in vivo repopulation assays (Mazurier et al, 2003).
Research on stem cells in other tissues, including epidermis
of the skin, has been hampered by the lack of reliable in vivo
assay systems. Improved in vivo repopulation assays that
are accurate, durable, and utilize bioengineered skin grafts
in the correct anatomical location are needed to character-
ize keratinocyte stem cells (KSC; Schneider et al, 2003; Li
et al, 2004).
To develop an improved competitive in vivo repopulation
assay that allows us to evaluate the relative abundance of
human KSC, we used grafts of bioengineered human skin
equivalents (HSE; Kolodka et al, 1998; Kuhn et al, 2002;
Pfutzner et al, 2002) composed of competing keratinocyte
populations that can be distinguished by the presence or
absence of an intrinsic genetic marker, MHC-class I HLA-
A2. Since HLA-A2 is positive in 30%–50% of the US pop-
ulation (Natali et al, 1989), competing keratinocyte popula-
tions, either HLA-A2-positive or -negative, can easily be
obtained. HSE composed of known numbers of HLA-A2-
positive and -negative cells are grafted onto immunocom-
promised mice to establish stable HSE, and the ratios
between A2-positive and -negative cells in the HSE are
monitored by an HLA-A2-specific monoclonal antibody and
flow cytometry (FACS). Since each keratinocyte stem cell is
believed to produce equivalent numbers of differentiated
progeny, extending upward from the basal layer toward the
skin surface (Potten and Allen, 1975; Kolodka et al, 1998),
the relative percentages of A2-positive and -negative ker-
atinocytes in HSE after many epidermal turnovers accu-
rately reflect the numbers of KSC in the initial A2-positive
and -negative populations. Initial populations that are en-
riched for KSC will yield a greater percentage of keratin-
ocytes within the HSE in long-term studies. To demonstrate,
however, that this in vivo assay is accurate and suitable for
competitive repopulation, it has to first be proved that A2-
positive and -negative cells repopulate the grafted HSE
equally well and are able to maintain their original ratio
following many epidermal turnovers.
The HSE used in our study were produced by a raft cul-
ture-grafting model (Pfutzner et al, 2002); human keratin-
ocytes were seeded onto a dermal equivalent that was
made of bovine type I collagen (Organogenesis, Canton,
Massachusetts) and contained primary human dermal fib-
roblasts (Fig 1a and b). HSE grafted on the backs of re-
cipient animals were stably maintained without loss or
shrinkage for more than 12 mo (Fig 1c). Immunohistochem-
istry with anti-human involucrin showed that the keratin-
ocytes within the HSE were exclusively of human origin and
had the histology of normal human epidermis (data not
shown). At the time of analysis, the whole HSE was excised
with the surrounding mouse skin, and processed with di-
spase and trypsin to prepare epidermal cell suspension. For
FACS analysis, living human cells (a blue box in Fig 1d )
were identified with anti-HLA-A, B, C, and 7-AAD (Fig 1d ),
and anti-HLA-A2, clone BB7.2, was used to evaluate the
percentages of HLA-A2-positive and -negative cells (Brod-
sky et al, 1979; Fig 1e).
To test our hypothesis that A2-positive and -negative
keratinocytes repopulate the HSE equally well and can sta-
bly maintain the original A2-positive/negative ratio in HSE,
we grafted a mixture with equivalent numbers of A2-positive
and -negative cells, which presumably contain equivalent
numbers of KSC, onto three strains of immunocompro-
mised mice (Swiss nude, NOD-scid and scid-beige), and
assessed the percentages of A2-positive cells by FACS at
26 wk, corresponding to more than six complete epidermal
turnovers (Fig 2). In all mouse strains tested, no significant
change in the percentages of A2-positive cells occurred
during the time course; p values were 0.59, 0.73, and 0.75
for Swiss nude, NOD-scid, and scid-beige, respectively.
There was also no significant difference between three
strains of mice at 5, 10, and 26 wk; p values were 0.58, 0.40,
and 0.29, respectively. In the real experimental setting to
test the long-term repopulation potential of stem cell can-
didates, the test population (stem cell candidate) with an
A2-positive phenotype would be mixed with the A2-nega-
tive control population (or vice versa). Prior to grafting
the HSE, the accurate plating efficiency of the A2-positive
and -negative populations needs be confirmed (e.g., by
FACS) to ensure that the in vivo assay accurately measures
the long-term repopulating ability of the initial A2-positive
Abbreviations: HSE, human skin equivalents; KSC, keratinocyte
stem cells
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and -negative populations. If the test population is truly en-
riched for stem cells, whereas the control is not, the per-
centage of A2-positive cells should increase over time to
predominate the HSE.
The use of an intrinsic HLA marker in our system has
advantages over cell-marking methods using viral vectors.
In contrast to variable percentages of keratinocytes ex-
pressing transduced viral markers, pure keratinocyte pop-
ulations that are completely A2-positive or -negative can
easily be obtained. Also, intrinsic markers avoid the risk of
introducing a growth advantage or disadvantage caused by
extrinsic molecules, and minimize the in vitro manipulation
that could harm the primitive nature of stem cells. Addi-
tionally, HLA-A2 differences can be detected on a genomic
level even if gene expression is lost. This system also per-
mits serial transplantation experiments, which have been
critical for demonstrating the self-renewal capacity of hem-
atopoietic stem cell candidates. The value of this assay is
that the repopulation ability of different KSC candidates can
Figure 1
The in vivo assay system to compare the relative abundance of repopulating cells in two populations of epidermal cells. Human epidermal
cells were prepared from six pieces each of HLA-A2-positive and -negative neonatal foreskins by enzymatic treatments (Pfutzner et al, 1999). The
equivalent numbers of A2-positive and -negative cells were mixed, and 600,000 cells were seeded onto a dermal equivalent prepared by established
methods to make human skin equivalents (HSE; Garlick and Taichman, 1994; a). HSE showed histology of close resemblance to the normal human
skin (b; E: epidermis; D: dermis). HSE were grafted on the backs of immunocompromised mice 3 d after seeding epidermal cells. The grafted HSE
(pigmented patch on panel c) were chased for 5–26 wk and harvested by wide excision containing the surrounding mouse skin. An epidermal cell
suspension was prepared by the enzymatic treatments and stained with anti-HLA-A, B, C (FITC-conjugate; BD Biosciences Pharmingen, San Diego,
California), anti-HLA-A2 (clone BB7.2; BD Biosciences Pharmingen) and 7-AAD (BD Biosciences Pharmingen) to identify living cells. Goat anti-
mouse IgG2b conjugated with AlexaFluor 647 (Molecular Probes, Eugene, Oregon) was used as a secondary antibody for BB7.2. Cells were analyzed
using FACSCalibur and CellQuest software (BD Biosciences Immunocytometry Systems, San Jose, CA). Living human cells gated with a blue box (d)
were evaluated for the percentages of HLA-A2-positive and -negative cells (e).
Figure2
The system stably maintained the 1:1 ratio between two popula-
tions of cells that should contain the equivalent numbers of re-
populating cells. The percentages of HLA-A2-positive cells in the HSE,
started with 47%, remained constant on the backs of immunocom-
promised mice (Swiss nude and scid-beige: Taconic, Germantown, NY;
NOD-scid: The Jackson Laboratory, Bar Harbor, Maine) for 5–26 wk
(n¼2–3 at each time point in each strain). Averages (  SEM) in one of
two independent sets of experiments with similar results are shown.
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be accurately compared in an anatomically correct in vivo
setting. The animal studies described in this manuscript
were approved by the National Cancer Institute (NCI) Animal
Care and Use Committee (ACUC).
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